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Abstract
In insects, a parental immune challenge can prepare and enhance offspring immune activity. Previous studies of such
transgenerational immune priming (TGIP) mainly focused on a single offspring life stage. However, different developmental
stages may be exposed to different risks and show different susceptibility to parental immune priming. Here we addressed
the question (i) whether TGIP effects on the immunity of Manduca sexta offspring vary among the different developmental
offspring stages. We differentiated between unchallenged and immunochallenged offspring; for the latter type of offspring,
we further investigated (ii) whether TGIP has an impact on the time that enhanced immune levels persist after offspring
immune challenge. Finally, we determined (iii) whether TGIP effects on offspring performance depend on the offspring
stage. Our results show that TGIP effects on phenoloxidase (PO) activity, but not on antibacterial activity, vary among
unchallenged offspring stages. In contrast, TGIP effects on PO and antibacterial activity did not vary among
immunochallenged offspring stages. The persistence of enhanced immune levels in immunochallenged offspring was
dependent on the parental immune state. Antibacterial (but not PO) activity in offspring of immunochallenged parents
decreased over five days after pupal immune challenge, whereas no significant change over time was detectable in
offspring of control parents. Finally, TGIP effects on the developmental time of unchallenged offspring varied among stages;
young larvae of immunochallenged parents developed faster and gained more weight than larvae of control parents.
However, offspring females of immunochallenged parents laid fewer eggs than females derived from control parents. These
findings suggest that the benefits which the offspring gains from TGIP during juvenile development are paid by the adults
with reduced reproductive power. Our study shows that TGIP effects vary among offspring stages and depend on the type
of immunity (PO or antibacterial activity) as well as the time past offspring immune challenge.
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Introduction
Insects defend themselves against pathogens and parasitoids by
their innate immune system. The effectiveness of this innate
immunity is shaped by several factors ranging from abiotic
parameters [1] to the type of food ingested ([2–4] and references
therein) or the immune challenges and risks experienced before
[5].
Numerous studies show that the experience of a microbial
infection or parasitic attack can improve the insects immune
response to a subsequent exposure to pathogens or parasitoids [6–
8]. Such ‘‘immune priming’’ by a first immune challenge may be
beneficial at environmental conditions at which subsequent
encounters of pathogens or parasitoids are likely and have an
impact on the fitness of the primed organism [9]. A priming effect
of an immune challenge on later immune responses can be traced
within a generation from an early juvenile stage to an elder one
[6,10], from a larval stage to the adult [7,11,12], and also within
the adult stage [13]. Several studies showed that immune priming
may even persist in the offspring generation. When pathogenic
threats experienced by the parental generation remain until the
offspring generation, transgenerational immune priming (TGIP)
may improve offspring survival. Some TGIP studies demonstrated
that an immune challenge of parental insects in their larval stage
can prime immune responses of a larval offspring stage [14–18],
while other studies showed that immunochallenged adult parental
insects can significantly prime the immune defence of their
offspring in the adult stage [19–22].
The studies of TGIP mentioned above focused on the analyses
of a priming effect on the immune state of a single, particular life
stage rather than tracking the priming effect across different stages
of the offspring generation from larvae to adults. However, in
unchallenged insects, the different ontogenetic life stages are
known to show different immune states [23]. Since the various life
stages are often exposed to different risks, TGIP might differen-
tially affect the immune state of different offspring stages and thus,
be of varying relevance throughout the life of an organism.
Even though an insect may benefit from immune priming by
improved resistance against pathogens or parasitoids, maintenance
and use of immune functions are well known to be costly (reviewed
in [24]). Costs and benefits of TGIP may differ according to the
risks experienced by the different developmental stages and the
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energy needed to establish and maintain a primed immune state.
For example, young larvae that usually suffer high risks of being
parasitized or preyed upon may be affected differently by TGIP
than elder larvae. Furthermore, pupae that are living in the soil
and are exposed to another microbial environment than stages
living above ground may be influenced differently by TGIP than
larvae and adults. However, so far TGIP effects have not been
traced yet from hatching offspring larvae to offspring adults. A few
recent studies have shown that TGIP is paid with worse offspring
performance expressed in terms of e.g. enhanced developmental
times until adult eclosion, reduced offspring weight, reduced F1
fecundity, and even enhanced offspring mortality [16,21,22].
In this study we used the tobacco hornworm Manduca sexta as a
model system in order to elucidate TGIP effects on immunity and
performance of the offspring throughout its entire development
from the larval stage to the adult. Development of the larvae which
feed upon the leaves of mainly solanaceous host plants takes five
instars; then the prepupal wandering stage digs a few centimetres
into the soil for pupation, and after about 21 days (depending on
abiotic conditions) the adult moths eclose from the soil [25]. The
2nd and 3rd instar larvae suffer a high mortality (approx. 90%) in
the field due to parasitism and predation [26–28]. Hence, survival
to pupation is strongly influenced by the risk that young larvae
experience by natural enemies [27,29]. The immune system of M.
sexta larvae is known to be able to respond to priming by a previous
immune challenge. An injection of a non-pathogenic bacterium
into the 5th instar of M. sexta larvae caused stronger immune
responses in the same instar and better survival of a subsequent
pathogen infection [10]. However, transgenerational immune
priming effects have not been studied yet in M. sexta.
We here addressed the following questions: (i) Does TGIP affect
the immunity of the various M. sexta offspring stages (larval instars,
pupae, adults) differently? We studied this question by differen-
tiating between unchallenged and challenged immune states of the
offspring. (ii) Does TGIP affect the persistence of enhanced
immune activity levels after offspring immune challenge? Are
enhanced immune activity levels of immunochallenged primed
offspring individuals maintained for a longer time than immunity
levels of immunochallenged non-primed ones? (iii) Does TGIP
affect performance of the various offspring developmental stages
differently?
In order to investigate TGIP effects on the different offspring
stages, the parental generation was challenged in its pupal stage by
injection of peptidoglycan (PGN), a non-pathogenic surface
molecule of bacteria that was dissolved in phosphate buffered
saline (PBS). For control, we analysed the immune state of the
offspring of PBS-control injected parents and of untreated (naive)
parental individuals. When studying immunity of immunochal-
lenged offspring of these three parental groups, the offspring
individuals were subjected to the same three different types of
treatments as the parental generation. M. sexta immune defence
levels were determined by measuring phenoloxidase (PO) activity
and antibacterial activity in haemolymph samples.
Binding of bacterial PGN to insect pattern-recognition proteins
leads to activation of different immune responses such as increase
of PO activity and antibacterial activity [30–33]. The activation of
the PO cascade and induction of the synthesis of antimicrobial
peptides (AMPs) have intensively been investigated in M. sexta
(reviewed in [34–36]). PO is an important enzyme that is involved
in melanisation and encapsulation of pathogenic or parasitic
invader [31,37]. Furthermore, oxidation reactions catalysed by
PO lead to the formation of toxic compounds that may contribute
to the killing of invading pathogens [38,39]. Induction of the PO
cascade follows a complex temporal pattern depending on the type
of immune challenge; PO activity can be upregulated within 1 h
after a pathogen attack and is then maintained for more than 24 h
[40,41]. PO activation and melanisation in response to microbial
exposure can occur faster than AMP synthesis [36]. The synthesis
of specific AMPs is induced in the insect haemolymph 2–48 h after
an immune challenge, and an induced level of antimicrobial
peptides can be maintained for 14 days [40,41].
Our findings show that TGIP effects strongly depend on the
offspring developmental stage studied, on the immune parameters
that were analysed (PO activity, antibacterial activity), on the
offspring immune state (unchallenged or challenged immune
state), and the time past immune challenge of the offspring.
Results
TGIP Effects on Immunity of Unchallenged Offspring
In order to investigate whether the impact of the parental
immune state on the immunity of unchallenged offspring varies
with the developmental stage of the offspring, we measured PO
and antibacterial activity of offspring individuals in their larval,
pupal and adult stages in dependence of the immune treatment of
their parents (three parental groups: PGN injected, PBS-control
injected, naive parents) (Fig. 1) (immunity levels of parental
treatment groups: Table S1, S2 in File S1).
PO activity of the unchallenged offspring generation was
significantly affected by the parental treatment (Table 1, two-
way-ANOVA, factor parental treatment, P,0.001) and the
offspring stage (Table 1, two-way-ANOVA, factor offspring
stage, P,0.001). The impact of the parental immune state on
the immunity of unchallenged offspring was dependent on the
developmental stage of the offspring (Table 1; two-way
ANOVA, significant interaction between parental treatment 6
offspring stage, P,0.001). PO activity of the unchallenged
offspring of all three parental groups was lowest in the 2nd
instar larvae, reached its peak in the larval wandering stage,
decreased during the pupal stage and increased again in the
adult stage (Fig. 1A). Unchallenged larvae of the 2nd to 4th
instar that were derived from parents treated with a PGN
injection or PBS-control injection showed a significantly higher
PO activity than unchallenged larvae of naive parents (Table
S3, post-hoc Tukey test in File S1). PO activity of offspring
larvae of PBS-control injected or PGN-immunochallenged
parents was always about as strong as the PO activity in the
following larval stage of offspring individuals derived from
unchallenged parents (Fig. 1A, Table S3 in File S1). No such
effects of the parental treatment on offspring PO activitiy were
detectable in the other offspring developmental stages studied.
Antibacterial activity of unchallenged offspring increased during
larval development and decreased thereafter in the pupal and
adult stage (Fig. 1B). This general trend was found in the offspring
of all three parental groups. Hence, antibacterial activity was
dependent on the developmental stage (Table 1, two-way
ANOVA, factor offspring stage, P,0.001, Table S4, post-hoc
Tukey test in File S1). However, antibacterial activity of all
developmental stages showed no differences in dependence of the
parental treatments (Table 1, two-way ANOVA, factor parental
treatment, P= 0.267).
Hence, while TGIP effects on PO activity of unchallenged
offspring varied with the developmental offspring stage studied,
TGIP effects on antibacterial activity did not.
TGIP Effects on Immunity of Challenged Offspring
In order to investigate whether the impact of the parental
immune state on the immunity of PGN-challenged offspring
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Figure 1. Transgenerational immune priming effects on immune activity of unchallenged Manduca sexta offspring. A) Phenoloxidase
activity and B) antibacterial activity (lysozyme activity equivalent, Micrococcus luteus) were measured during offspring development at the first day of
each developmental stage and in 22-day-old pupae. Female and male parents received a priming treatment in their pupal stage: Naive) untreated,
PBS) control-injected with phosphate buffered saline, PGN) injected with peptidoglycan. If the symbol for offspring of naive parents is not visible, it is
overlaid by another symbol. Means 6 SE are given. N=9 samples of each developmental stage from each parental group. Differences between the
parental priming treatments and the offspring developmental stages were compared by 2-way-ANOVA (Table 1) and post-hoc analysis Tukey tests
(Table S3 for PO activity, table S4 for antibacterial activity in File S1).
doi:10.1371/journal.pone.0063392.g001
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varies with the developmental stage of the offspring, we
measured PO and antibacterial activity of offspring individuals
after an immune challenge. The offspring individuals of the
three parental groups were challenged with a PGN injection in
their 4th larval stage. Furthermore, other offspring individuals of
the three parental groups were challenged in the same way in
the pupal stage (21-day-old pupae). We measured offspring PO
and antibacterial activity one day after treatment (L4-larvae, 22-
day-old pupae) and determined how these immune parameters
differ from immunity of the respective unchallenged stages.
Figure 2 shows how the PO or antibacterial activity level
changed after an immune challenge when compared to the PO
or antibacterial activity level of unchallenged offspring individ-
uals (value 1 = no change).
An immune challenge of offspring larvae and pupae by PGN-
injection did not lead to an increase of PO activity as compared to
the activity in unchallenged larval offspring individuals (Fig. 2A,
values about 1 to 2). This finding was independent of the parental
group the offspring was derived from (Table 2, two-way ANOVA,
factor parental treatment, P= 0.469, Table S5, absolute data in
File S1).
For control, we also measured the PO activity of larvae and
pupae that were PBS-control injected. No increase of PO activity
was found in these larvae and pupae when compared to untreated
ones of each parental treatment group (Table S5 in File S1). Their
PO activity was neither affected by the parental treatment nor by
the offspring stage (Table S6, two-way ANOVA in File S1).
In contrast, antibacterial activity of the offspring larvae and
pupae was strongly induced one day after offspring PGN
treatment (Fig. 2B). The intensity of induction of antibacterial
activity in these offspring stages was dependent on the parental
treatment (Table 2, two-way ANOVA, factor parental treatment,
P,0.001). In larvae of control parents, the offspring PGN
treatment led to an about 6-fold increase of antibacterial activity,
whereas in larvae of PGN parents the offspring PGN treatment led
to an about 13-fold increase of antibacterial activity (Fig. 2B,
Table S5, absolute data in File S1). In 4th instar larvae, the
antibacterial activity after PGN treatment was stronger than
antibacterial activity in all unchallenged offspring developmental
stages, independent of the parental treatment (Table S5 in File S1).
PGN-treated offspring pupae of control parents showed an about
3-fold increase of antibacterial activity, whereas PGN-treated
offspring pupae of PGN-treated parents showed an about 5-fold
increase of antibacterial activity; their antimicrobial activity was
higher than in all unchallenged developmental stages (Fig. 2B,
Table S5 in File S1). Hence, the parental PGN treatment
significantly affected the level of induction of antibacterial activity
in larvae and pupae (Table 2, two-way ANOVA, factor parental
treatment, P,0.001). The immune levels significantly differed with
the offspring stage studied (Table 2, two-way ANOVA, factor
offspring stage, P,0.001). However, no significant interaction was
detected between the parental treatment and offspring stage
(Table 2, two-way ANOVA, factor parental treatment6offspring
stage, P= 0.241).
For control, we also tested the antibacterial activity of larvae
and pupae that were PBS-control injected. However, these larvae
and pupae neither showed an increase of antibacterial activity
(Table S5, absolute data in File S1) nor effects of parental
treatment or offspring stage on the PBS-induced antibacterial
activity of the offspring (Table S6, two-way ANOVA in File S1).
Hence, no indication was found that TGIP effects on
immunochallenged offspring immunity (PO or antibacterial
activity) vary with the ontogenetic offspring stage studied here.
TGIP Effects on Persistence of Challenged Offspring
Immunity
We investigated how the parental immune challenge affects the
persistence of enhanced immune activity in offspring that had
been challenged by PGN. We analysed (i) for how long enhanced
immune activity levels of offspring individuals are maintained after
an immune challenge and (ii) how this depends on the parental
immune challenge. We examined whether an increase of immune
activity of offspring pupae after PGN challenge two days prior to








Parental treatment df = 2 df = 2
MS= 1.257 MS= 0.008
F = 16.040 F = 108.434
P,0.001 Naive – PBS: P,0.001 P= 0.267
Naive – PGN: P,0.001
PBS – PGN: P= 0.992
Offspring stage df = 7 df = 7
MS= 4.351 MS= 0.679
F = 55.533 F = 1.328
P,0.001 P,0.001 Table S4 in File S1
Parental treatment x df = 14 df = 14
Offspring stage MS= 0.286 MS= 0.005
F = 3.655 F = 0.752
P,0.001 Table S3 in File S1 P=0.720
Statistical evaluation (two-way ANOVA) of the priming effects on phenoloxidase (PO) and antibacterial (AMP) activity (lysozyme activity equivalent, Micrococcus luteus)
of unchallenged Manduca sexta offspring from differently treated parents (naive, PBS, PGN) (compare Fig. 1 and Tables S3, S4 for post hoc test data in File S1).
Data were Box-Cox transformed prior to analysis in order to reach normal distribution PO= PO‘0.185, AMP=AMP‘0.095. Significant P-levels are shown in bold.
doi:10.1371/journal.pone.0063392.t001
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adult emergence is still maintained in the offspring adults (Fig. 3).
We measured immune activity levels of one set of adults that were
1 day old (i.e. 3 days after they have received a PGN injection in
their pupal stage) and of another set of adults that were 3 days old
(i.e. 5 days after they have received a PGN injection in their pupal
stage). Figure 3 shows how the immune parameters of these adults
differ from immunity of the respective unchallenged adults (value
1: no change).
As was found for PGN-challenged L4-larvae and the 22-day-old
offspring pupae (Fig. 2), the PO activity of PGN-challenged 1- and
3-day-old offspring adults was not affected by parental treatment
(Fig. 3A, Table 3, P= 0.102, Table S5 in File S1). However,
antibacterial activity of the offspring adults was significantly
affected by the parental treatment (Fig. 3B, Table 3, factor
parental treatment, P,0.05, Table S5, absolute data in File S1).
The increase of PGN-induced antibacterial activity in the offspring
adults was dependent on the time after their immune challenge
(Table 3, factor time after challenge, P,0.001). Five days after
offspring immune challenge, antibacterial immune activity of
offspring adults with PGN-challenged parents was the lowest
(value = 1, i.e. no increase of immune activity) when compared to
an about 3-fold increase of antibacterial activity in offspring adults
with PBS-treated and control parents (Table S7, post hoc Tukey
test in File S1).
Hence, the effect of the parental treatment on the persistence of
antibacterial activity significantly differed with the time past
offspring PGN-challenge (Table 3, factor parental treatment 6
time after challenge, P,0.05).
For control, we also tested PO and antibacterial activity of
adults that were PBS-control injected in their pupal stage. Their
immune parameters were independent of the parental treatment
(Table S8, two-way ANOVA in File S1). The time after offspring
PBS-challenge in the pupal stage had a significant effect on the
PO-level of the resulting adults, but did not affect the antibacterial
activity of the adults (Table S8 in File S1). Furthermore, no
significant interactive effect of parental treatment 6 time past
challenge on PO activity and antibacterial activity was found in
adults that were challenged by PBS in the pupal stage (Table S8 in
File S1). Thus, in contrast to the TGIP persistence effects on
antibacterial activity observed after offspring PGN-challenge
(Table 3, factor parental treatment 6 time after challenge,
P,0.05), no such effects were detected for PBS-challenged
offspring; the effect of the parental treatment on the persistence
of PBS-induced antibacterial activity in the offspring did not
depend on the time past offspring PBS challenge (Table S8 in File
S1).
Figure 2. Transgenerational immune priming effects on the increase of immune activity of Manduca sexta offspring larvae and
pupae one day after offspring immune challenge by PGN. A) Increase of phenoloxidase (PO) activity and B) increase of antibacterial (AMP)
activity (lysozyme activity equivalent, Micrococcus luteus) were measured in 4th instar larvae and 22-day-old pupae one day after offspring immune
treatment. Female and male parents received a priming treatment in their pupal stage: Naive) untreated, PBS) control-injected with phosphate
buffered saline, PGN) injected with peptidoglycan. If the symbol for offspring of naive parents is not visible, it is overlaid by another symbol. Increase
of immune activity was measured as increase= (Activity after PGN treatment of the offspring)/(Mean activity of unchallenged offspring); value 1 is
labelled by a line that indicates no change in immune activity after offspring challenge. Please note the comparable scales for increases which show
the immunity and visualise the strong priming effects on offspring AMP activity, but the lack of effects on PO activity in the offspring. Mean values6
SE are given. N= 9 individuals of each developmental stage from each parental group. Means of absolute data of PGN- and PBS-treated offspring are
shown in Table S5 in File S1. Differences between the parental priming treatments and the offspring developmental stages were compared by 2-way-
ANOVA (Table 2). Statistical evaluation of priming effects on the increase of immunity after offspring immune challenge by PBS is shown in Table S6
in File S1.
doi:10.1371/journal.pone.0063392.g002
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TGIP Effects on Weight and Developmental Time of
Unchallenged Offspring
In order to elucidate the impact of a parental priming treatment
on the performance of the different offspring stages, we compared
developmental times and weight of juvenile and adult stages of
unchallenged offspring of the three parental treatment groups.
Figure 4 shows how weight and development times of the different
offspring stages of PBS- or PGN-treated parents differed from the
performance parameters of the respective stages derived from
unchallenged parents (value 1 = no difference).
The parental treatment significantly affected weight of the
offspring stages. Except for 4th instar larvae, offspring of PBS- or
PGN-injected parents gained more weight than offspring of naive
parents (Fig. 4A, Table 4, factor parental treatment, P,0.001,
Table S9, absolute data in File S1). The changes in weight after
PBS and PGN treatment were dependent on the offspring stage
studied (Table 4, factor offspring stage, P,0.001, Table S10, post-
hoc Tukey test in File S1). However, no significant interaction was
detected between the parental treatment and offspring stage
(Table 4, factor parental treatment 6 offspring stage, P,0.143).
Therefore, the effects of the parental immune treatment on
offspring weight did not significantly change with the ontogenetic
offspring stages studied.
In contrast, the impact of the parental treatment on offspring
developmental time were significantly dependent on the
ontogenetic offspring stage (Table 4, factor parental treatment
6 offspring stage, P,0.001, Table S9, absolute data in File S1).
Young larvae (2nd and 3rd instar) and the wandering larval stage
derived from PGN-treated parents showed a significantly shorter
developmental time than larvae of untreated parents, whereas
the L5 stage of PGN-treated parents showed a longer
developmental time than those of untreated parents (Table
S11, post-hoc Tukey test in File S1). The duration of the pupal
and adult stage of offspring derived from PGN treated parents
did not significantly differ from the duration of the respective
stages derived from untreated parents (Table S11 in File S1).
Fecundity
The effects of the parental immune treatment on fecundity of
adults were dependent on the generation studied (Table 5, two-
way ANOVA, parental treatment6 generation factor, P,0.001).
Treatments of the parental generation in the pupal stage with PBS
or PGN had no effect on the fecundity of adults in the parental
generation (Fig. 5). However, the parental priming treatment
significantly affected fecundity of unchallenged offspring. Mated
offspring females of PGN-treated parents laid only about a quarter
of the eggs compared to the number of eggs laid by offspring
females of control parents (Fig. 5).
Discussion
Our study showed that a parental immune challenge of M. sexta
with PGN had different effects on the immune activity and
performance of the various offspring life stages when these were
kept unchallenged. In contrast, TGIP effects on the immune
activity of immunochallenged offspring did not vary among the
offspring stages. TGIP also affected the persistence of increased
immune activity of offspring that was immunochallenged. The
various TGIP effects on immune activities of the offspring life
stages were also dependent on the immune parameter studied, i.e.
PO activity and antibacterial activity.
TGIP Effects on Immunity of Unchallenged Offspring
PO activity of the different unchallenged offspring stages was
differently affected by TGIP (Fig. 1A, Table 1). A TGIP effect on
PO activity was traceable until the 4th instar of unchallenged
offspring larvae of PGN- and PBS-challenged parents when
compared to offspring larvae of untreated control parents,
indicating that the enhanced PO activity in the primed larvae
was due to the parental experience of an injection treatment and
thus, a slight injury rather than to exposure to pathogens or
bacterial surface molecules like PGN (Fig. 1A, Table S3 in File S1).
PO is well known to be released from specialised haemolymph
cells in response to physical injury; several studies strongly indicate
that PO plays a role in haemolymph coagulation and thus in
wound healing [42]. Interestingly, PO activity was not enhanced
in the parents after injection of PBS or PGN into the fully
sclerotized 21-day-old pupae (Table S1 in File S1), but only in
their non-challenged larval offspring. This result suggests that the
immune system of offspring larvae with their soft bodies can be
prepared for a physical injury by an experience of just a slight
wounding in the parental pupal stage. However, a study of the
moth Trichoplusia ni has shown that an increase of PO activity may
also occur in larval offspring when the parents had not been
challenged by wounding, but were exposed to dietary bacteria
[16]. PO-generated reactive compounds may contribute to
intoxication of bacteria and fungi [39]; hence, an increased
cytotoxic defence may help cope better with bacteria and fungi in
an unpredictable environment.
We could not detect a TGIP effect on antibacterial activity of
the unchallenged offspring stages of M. sexta studied here
(Fig. 1B, Table 1), even though antibacterial activity of the
parental pupae and adults were significantly enhanced after the





activity post hoc Tukey test
Parental treatment df = 2 df = 2
MS= 0.053 MS= 0.006
F = 0.768 F = 16.555
P=0.469 P,0.001 Naive - PBS: P=0.959
Naive - PGN: P,0.001
PBS - PGN: P,0.001
Offspring stage df = 1 df = 1
(L4, pupae) MS = 0.0007 MS= 0.021
F = 0.010 F = 55.761
P=0.922 P,0.001
Parental treatment x df = 2 df = 2
Offspring stage MS= 0.004 MS= 0.0006
F = 0.062 F = 1.465
P=0.940 P= 0.241
PGN=peptidoglycan. Statistical evaluation (two-way-ANOVA) of priming effects
on the increase of phenoloxidase (PO) and antibacterial (AMP) activity
(lysozyme activity equivalent, Micrococcus luteus) of Manduca sexta offspring
from differently treated parents (naive, PBS, PGN) one day after offspring PGN
treatment in 4th instar larvae and 22-day-old pupae (Fig. 2). Means 6 SE of PO
activities and antibacterial activities of PGN-challenged offspring individuals are
shown in Table S5 in File S1. Statistical evaluation of priming effects on the
increase of immunity after offspring immune challenge by PBS is shown in
Table S6 in File S1.
Data were Box-Cox transformed prior to analysis in order to reach normal
distribution PO=POˆ0.318, AMP=AMPˆ0.046. Significant P-levels are shown in
bold.
doi:10.1371/journal.pone.0063392.t002
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PGN immune challenge in the parental pupal stage (Table S1
in File S1). Once produced, AMPs may persist for some time
since their highly compact structure hampers access of proteases
[43]. This may explain maintenance of high AMP activity in
parental adults after treatment in the pupal stage. However, the
lack of a TGIP effect on the antibacterial activity of
unchallenged offspring larvae may be due to the diverging risks
that are experienced by adults and larvae. Larvae usually leave
their natal site and thus, are exposed to other risks than the
parents. Hence, as long as larvae do not face a bacterial
challenge, TGIP of antibacterial activity of unchallenged
offspring stages of M. sexta might be too costly when considering
the unpredictability of the disease that will be experienced by
the offspring. However, as soon as offspring larvae need to cope
with a bacterial challenge, they appear to be ‘‘prepared’’ for this
challenge if their parents have experienced an immune
challenge (see Fig. 2B; and below ‘‘TGIP effects on immunity
of challenged offspring’’).
In contrast to our findings, antibacterial activity of non-
challenged larvae of the philopatric insect Tenebrio molitor was
enhanced when their parents experienced a bacterial challenge
by injection of lipopolysaccharides (LPS) in the larval stage.
Larval T. molitor PO activity was not affected by the parental
immune challenge [15]. Different T. molitor generations may
spend their development in the same, stable environment (e.g.
in a mill), and therefore they might encounter very similar risks.
Thus, it might be beneficial if the immune challenge
experienced by the parental generation primes an immunolog-
ical trait that addresses the likely risks that will also be
experienced by the offspring. Similarly, TGIP effects on
offspring immunity that were found in the bumblebee Bombus
terrestris have been suggested to be adjusted to the risk
experienced by the unchallenged offspring. A bacterial challenge
of B. terrestris queens by injection of LPS enhanced the PO
activity of unchallenged offspring males that leave the colony
and are likely to encounter different pathogens [43]. In contrast,
unchallenged females that remain in the nest and encounter the
same disease environment as the queen showed an enhanced
antibacterial activity which provides a narrower immunity than
the one provided by the PO system [43].
TGIP Effects on Immunity of Challenged Offspring
TGIP effects on PO and antibacterial activity of PGN-
challenged offspring did not significantly depend on the develop-
mental offspring stage studied (Fig. 2A, B, Table 2). In contrast to
the TGIP effect on PO activity of unchallenged M. sexta, no such
effect on PO activity was detectable anymore when offspring
larvae experienced an immune challenge by PGN injection.
However, TGIP affected the antibacterial activity of the PGN-
challenged offspring; the effect was traceable until the pupal stage
of the offspring from PGN parents. Both the offspring larvae and
pupae with PGN parents showed enhanced antibacterial activity
one day after PGN challenge, i.e. after experiencing the risk of
bacterial infection. Hence, TGIP effects on PGN-induced
antibacterial activity did not differ between offspring larvae and
pupae.
Figure 3. Persistence of transgenerational immune priming effects on the increase of immune activity of Manduca sexta offspring
after offspring immune challenge by PGN in 21-day-old pupae. A) Increase of phenoloxidase (PO) activity and B) increase of antibacterial
(AMP) activity (lysozyme activity equivalent, Micrococcus luteus) were measured in 1-day-old and 3-day-old adults, i.e. three and five days,
respectively, after offspring immune treatment in 21-day-old pupae. Female and male parents received a priming treatment in their pupal stage:
Naive) untreated, PBS) control-injected with phosphate buffered saline, PGN) injected with peptidoglycan. If the symbol for offspring of naive parents
is not visible, it is overlaid by another symbol. Increase of immune activity was measured as increase = (Activity after PGN treatment of the offspring)/
(Mean activity of unchallenged offspring); value 1 is labelled by a line that indicates no change in immune activity after offspring challenge. Please
note the comparable scales for increases which show the immunity and visualise the strong priming effects on offspring AMP activity, but the lack of
effects on PO activity in the offspring. Mean values6 SE are given. N= 9 individuals of each developmental stage from each parental group. Means of
absolute data of PGN- and PBS-treated offspring are shown in Table S5 in File S1. Differences between the parental priming treatments and the time
intervals after offspring PGN treatment were compared by two-way ANOVA (Table 3) and post hoc analysis Tukey tests (Table S7 in File S1). Statistical
evaluation of priming effects on the persistence of immunity after offspring immune challenge by PBS is shown in Table S8 in File S1.
doi:10.1371/journal.pone.0063392.g003
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TGIP Effects on Persistence of PGN-challenged Offspring
Immunity
The TGIP effects on PGN-induced offspring antibacterial
activity were dependent on the time past offspring challenge
(Fig. 3B, Table 3). In contrast to offspring derived from control
parents, 3-day-old adults from PGN-treated parents were unable
to maintain an induced level of antibacterial activity five days after
the PGN-treatment in the pupal stage (Table S7 in File S1). The
duration of increased antibacterial activity in insect haemolymph
ranges between days and weeks (summarized in [41]). Our results
show that the parental immune legacy may shorten the duration of
increased immune activity in the offspring. Innate immunity and
metabolism of insects has been shown to be closely linked, and the
production of antimicrobial peptides depends on the energy status
of the cells [44]. The resources for mounting enhanced immune
activity in the offspring adults derived from PGN-treated parents
might have been exhausted after (i) deployment of increased
inducibility of antibacterial activity in response to a PGN-
challenge in the pupal stage compared to pupae of control parents
(Fig. 2B) and/or (ii) maintenance of enhanced immune activity
throughout the entire juvenile development (Fig. 1).
Developmental Stage and Offspring Immunity
Independent of TGIP, immune activity measured as PO and
antibacterial activity increased in the offspring generation from the
second larval stage to the prepupal stage (Fig. 1). These findings
reflect the patterns of susceptibility of insects to parasitoids and
pathogens; young insect larvae usually show a higher risk of being
parasitized than older ones and are less resistant against parasitism
[45]; furthermore, the susceptibility to pathogen infection often
decreases with increasing larval stage [46]. While in our study
offspring immune activities increased about 2- to 3-fold in
response to a parental immune challenge, offspring immune
activities increased more than 10-fold during larval development
regardless of the parental immune state. Hence, the developmental
stage has an enormous impact on the level of immune activity.
The decrease of immune activities in the pupal and adult stage
(Fig. 1) might be explained by the formation of a hard exoskeleton
in the pupae. The hard cuticle is usually regarded as an effective
first barrier against pathogens and parasites [47] and thus, may
take on an important task of defence. After the pupal stage, PO
activity increased again in the unchallenged offspring adults, which
might be due to the high risk of wounding for the moths when
actively flying around searching for mates or oviposition sites. In
contrast, antibacterial activity of unchallenged offspring adults
stayed at a low level, but could easily be induced when it was
needed (after PGN-challenge; Fig. 3B). As the PO cascade
provides a broader immunity and can be induced more quickly
than the costly antibacterial immune response [47], adults may
benefit from keeping the most general means of immune defence
(the PO system) at an enhanced level. Adult honeybees showed an
increasing level of PO activity with increasing age and a
decreasing number of haemocytes the older they are [48]; a
programmed change in immune functions, from cellular-based to
PO-based immunity was observed in the course of ageing of adult
bees. Variation of non-primed immune activity across develop-
mental stages of other insects than M. sexta has been shown in
several studies [23,49–51]. All studies showed that the immune
state of the different life stages change in the course of the
individuals ontogenesis. The stage-specific immune activities may
be adapted to the stage-specific needs of the respective species.
TGIP Effects on Performance of Unchallenged Offspring
TGIP effects on offspring performance were dependent on the
ontogenetic offspring stage when considering developmental time
of the offspring as performance parameter (Fig. 4B, Table 4). In
the field, M. sexta suffers a high mortality (approx. 90%) caused by
parasitoids and predators which mainly attack the young larval
stages [26–28]. A field study with M. sexta showed that rapid larval
development was associated with higher survival to pupation and
thus, was suggested to allow larvae to escape from attack by
natural enemies [28]. Therefore, a shorter developmental time of
2nd and 3rd instar larvae in offspring of PGN-parents – as was
found here (Table S11 in File S1) - may be beneficial, since this
lowers the high predation and parasitisation risk of these stages.
TGIP effects on offspring performance did not depend on the
offspring developmental stage when considering offspring weight
(Table 4). Almost all stages derived from parents that experienced
PBS- or PGN-injection gained benefit from parental immune
priming in terms of higher weight. The parental treatment effects
on larval weight and developmental time found here were detected
when feeding larvae ad libitum with artificial diet. Whether TGIP
would still affect offspring weight and developmental time when
larvae would be provided with limited food resources – as it might
occur in the field – remains to be investigated by future studies.
The positive TGIP effects on M. sexta weight and developmental
time contrast other studies of other insect species which showed
worse performance of offspring of immunochallenged parents
[16,21,22]. However, in our study, the benefits that especially
young larval M. sexta stages gained when their parents had been
immunochallenged were at the cost of fecundity of offspring
adults. Heavier offspring females of PGN-challenged parents laid
unexpectedly fewer eggs than lighter offspring females of control
parents (Fig. 4A, 5). Heavy pupae with high fecundity [28] are
usually expected to contain large ovaries and more eggs than






Parental treatment df = 2 df = 2
MS= 0.035 MS= 0.029
F = 2.399 F = 4.965
P= 0.102 P,0.05
Time after offspring df = 1 df = 1
challenge in pupal stage MS= 0.003 MS= 0.077
(3 d, 5 d) F = 0.189 F = 12.938
P= 0.666 P,0.001
Parental treatment x df = 2 df = 2
Time after challenge MS= 0.023 MS= 0.027
F = 1.570 F = 4.628
P= 0.219 P,0.05 Table S7 in File S1
PGN=peptidoglycan. Statistical evaluation (two-way-ANOVA) of priming effects
on the persistence of the increase of phenoloxidase (PO) and antibacterial
(AMP) activity (lysozyme activity equivalent, Micrococcus luteus) three and five
days after offspring pupal PGN treatment in 3-day-old and 5-day-old adults
(Fig. 3). Means 6 SE of PO activities and antibacterial (AMP) activities of PGN-
challenged offspring individuals are shown in Table S5 in File S1. Statistical
evaluation of priming effects on the persistence of enhanced immune activity
after offspring immune challenge by PBS is shown in Table S8 in File S1.
Compare Table S7 for post hoc test data in File S1.
Data were Box-Cox transformed prior to analysis in order to reach normal
distribution PO=POˆ0.242, AMP=AMPˆ0.121. Significant P-levels are shown in
bold.
doi:10.1371/journal.pone.0063392.t003
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smaller pupae. In our study, the heavy pupae of PGN-parents may
have been rather filled with a large fat body that produced
antimicrobial peptides [47] than with large ovaries. Reduced
fecundity of offspring adults was found in Tribolium castaneum
offspring that derived from fathers that experienced an immune
challenge, whereas an immune challenge of the mother had no
effect on the fecundity of the adult offspring [21]. We did not
differentiate between maternal and paternal TGIP effects since we
Figure 4. Transgenerational immune priming effects on weight and developmental time of unchallenged Manduca sexta offspring.
Change (increase/decrease) in weight (A) and developmental time (B) of offspring derived from naive parents and offspring of PBS- or PGN-treated
parents were calculated for each offspring stage of each parental group as ratio = (Individual weight or developmental time of offspring of the
respective parental treatment group)/(Mean weight or developmental time of offspring derived from naive parents). Larval weight was determined at
the last day of each instar, whereas pupal and adult weight was determined at the first day of the respective stage. Value 1 is labelled by a line that
indicates no change in weight or developmental time compared to offspring derived from naive parents. Female and male parents received a
priming treatment in their pupal stage: Naive) untreated, PBS) control-injected with phosphate buffered saline, PGN) injected with peptidoglycan. If
the symbol for offspring of naive parents is not visible, it is overlaid by another symbol. Mean ratios 6 SE are given. N= 18 individuals of each
developmental stage except for adults N=9 from each parental group. Means of absolute data of offspring weight and developmental time are
shown in Table S9 in File S1. Differences between the parental priming treatments and the offspring developmental stages were compared by
Generalized linear model (Table 4) and post hoc analyses U-test (Table S10 weight, table S11 developmental time in File S1).
doi:10.1371/journal.pone.0063392.g004
Change of Insect Immunity during Development
PLOS ONE | www.plosone.org 9 May 2013 | Volume 8 | Issue 5 | e63392
focused on the elucidation of TGIP effects on the various offspring
stages rather than on the maternal and paternal contribution to
TGIP. If in nature transgenerationally primed M. sexta offspring
individuals will show a higher survival rate because of faster
development and higher level of immunocompetence when facing
pathogen infection and parasitoid attack during their juvenile
development, more offspring females would be able to lay eggs and
to establish the next generation. Such a higher number of offspring
females derived from PGN-treated parents might balance their
lower fecundity when considering population growth.
Conclusions
Our results show that the different ontogenetic offspring stages
of M. sexta respond stage-specifically to the parental immune
legacy. The parental immune challenge primes PO activity of their
unchallenged young larvae (L2 to L4) which are in the field
exposed to a high risk of parasitism and predation; TGIP further
leads to a reduction of the developmental time of these stages and
thus, provides the young offspring with traits that might improve
their ability to cope with carnivorous enemies. The parental
immune challenge further primes antibacterial activity of PGN-
challenged larvae and pupae which are exposed to the risk of
pathogenous infection especially in the pupal stage when digging
into the soil. However, our data indicate that the adult offspring
needs to pay for the benefits that they gain during juvenile
development from TGIP. When exposed to an immune challenge,
adult offspring of immunochallenged parents showed a reduced
ability to maintain high antibacterial activity for a longer time;
furthermore, offspring adults of immunochallenged parents
showed reduced fecundity. We suggest that the TGIP effects are
adapted to the needs and the risks of each offspring developmental
stage.
Table 4. Performance of unchallenged offspring.
Source Weight post hoc U- test Developmental Time post hoc U- test
Parental treatment df = 2 df = 2
LR Chisq = 81.225 LR Chisq = 8.538
P,0.001 Naive – PBS: P,0.001 P,0.05
Naive – PGN: P,0.001
PBS – PGN: P=0.195
Offspring stage df = 5 df = 6
LR Chisq = 34.131 LR Chisq = 118.352
P,0.001 Table S10 in File S1 P,0.001
Parental treatment x df = 10 df = 12
Offspring stage LR Chisq = 14.711 LR Chisq = 92.243
P= 0.143 P,0.001 Table S11 in File S1
Statistical evaluation (Generalized linear model; post hoc U-test) of priming effects on the change of weight and developmental time of (unchallenged) Manduca sexta
offspring due to parental treatment (naive, PBS, PGN) (Fig. 4A). Means 6 SE are shown in Table S9 in File S1. Significant P-levels are shown in bold.
doi:10.1371/journal.pone.0063392.t004
Figure 5. Reproductive fitness of Manduca sexta females in the
parental and offspring generation. Total number of eggs laid by
females of the differently treated parental generations and by the
resulting (untreated) offspring generation. Female and male parents
received a priming treatment in their pupal stage: Naive) untreated,
PBS) control-injected with phosphate buffered saline, PGN) injected
with peptidoglycan. Untreated offspring females mated with untreated
males that were originating from parents subjected to the same
parental priming treatment. Means 6 SE are given. N= 8 individuals
from each parental group. Statistics: 2-way-ANOVA, post hoc analysis
Tukey-test (Table 5), Tukey-test: different letters indicate statistical
differences (P,0.01).
doi:10.1371/journal.pone.0063392.g005
Table 5. Fecundity of parental and unchallenged offspring
females.
Source df MS F P
Parental treatment 2 168728 10.26 ,0.001
Generation 1 92225 5.61 ,0.05
Parental treatment6Generation 2 96913 5.89 ,0.001
Statistical evaluation (two-way ANOVA) of reproductive fitness of Manduca
sexta females after immune treatment (naive, PBS, and PGN) of the parental
generation and of their unchallenged offspring (Fig. 5). Significant P-levels are
shown in bold.
doi:10.1371/journal.pone.0063392.t005
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Overall, our study revealed that TGIP effects on the offspring
strongly depend on the ontogenetic offspring stage studied, the
immune and performance parameter that is considered and the
time past offspring immune challenge. There is growing evidence
that insect immune responses show specificity with respect to the
pathogen that is faced [52,53]. Furthermore, the food, gut
microbiota, and social interactions may affect insect immunity
[4]. Hence, the effects of TGIP on offspring immunity are shaped
by a multifaceted range of factors and thus, immunoprimed
offspring individuals may be able to fine-tune their immune
responses to parasitoids and pathogens with respect to their age,
their risks and the prevailing environmental conditions.
Materials and Methods
Insect Culturing
Manduca sexta were reared in the laboratory at 24uC, 70% r.h.,
and a 16:8 h L:D cycle. Larvae were fed ad libitum on a wheat
germ based diet (240 g wheat germ, 50 g casein, 35 g agar, 16 g
Wesson salt mix, 8 g ascorbic acid, 4 g sorbic acid, 2 g methyl-p-
hydroxybenzoate, 20 mg nicotinic acid, 10 mg riboflavin, 4.7 mg
thiamin, 4.7 mg pyroxidine, 4.7 mg folic acid, 0.4 mg biotin, and
40 mL 4% formaldehyde per 1.2 L water). Eggs, larvae and pupae
were kept in boxes of different sizes (approx. 100 eggs, 100 L1 or
50 L2 instars in 2062066 cm boxes; approx. 30 L3 or 30 L4
instars in 21636613 cm boxes; 10–20 L5 instars in
26641615 cm boxes; 3–5 wandering L5 instars or 10 pupae
separated by sexes in 1361766 cm boxes). Each developmental
stage was always available in the rearing. Eclosing adults were
allowed to mate inside flight cages (50650650 cm, approx. 6
females and 6 males per cage) and were provided with 10%
aqueous honey solution and a tobacco leaf for stimulation of
oviposition. The tobacco leaf was placed on the top of a glass jar
(250 mL) that was wrapped with parafilm. The parafilm also fixed
the margins of the leaf to the jar. Moths preferred to lay eggs on
the parafilm while landing on the tobacco leaf and then curling
their abdomen to the parafilm-wrapped glass jar. Eggs could easily
be removed from the parafilm and were used for further rearing.
The leaf was replaced every other day by a fresh one taken from
tobacco plants (about 6 weeks old) that were grown in the
greenhouse.
Priming Treatment in the Parental Generation
The parental and offspring generation were reared at the same
abiotic conditions as described above.
For the priming treatment of the parental generation, we used
M. sexta pupae 21 days after pupation (Table S1, S2 in File S1).
Female pupae of this age always showed completely developed
ovaries (observed by dissection of 14- to 21-day-old pupae). The
priming treatment of the parental generation was conducted in
pupae of this age, since we wanted to expose the parental
generation to an immune challenge just prior to egg maturation,
i.e. just prior to the onset of formation of the next generation. The
first mature eggs were found in M. sexta ovaries 24 h after eclosion
of adults [54]. Both male and female pupae of the parental
generation were subjected to an injection of peptidoglycan
extracted from Micrococcus luteus (PGN, Sigma 53243). For control,
males and females were injected a phosphate buffered saline (PBS;
7 mM KH2PO4, 3 mM Na2HPO4, 0.13 M NaCl, pH 7.4) or
were left untreated (no challenge, naive). Hence, three different
parental groups were generated.
Disposable 1 mL polypropylene insulin syringes (BD Consumer
Healthcare, Franklin Lakes, USA) were used for injections. Each
PBS-treated pupa received an injection of 50 mL PBS solution
dorsally into the first abdominal segment after being chilled on ice.
Each PGN-challenged pupa received a 2 mg mL21 dose of PGN
extracted from M. luteus in 50 mL sterile PBS solution after being
chilled on ice.
When referring to adult parents, these were only adults which
eclosed 2 days after pupal treatment, and which were in the adult
stage for 1 or 3 days (see below). Since an individual’s immune
response is dynamic over time [40,55], 3-day-old adults of each
parental group were used for production of the offspring
generation. After eclosure, adults were kept in cages
(50650650 cm; four females and four males of the same priming
treatment per cage). The immune priming treatment of the
parental generation by PGN injection led to an increase of
antibacterial activity in the parental pupae and adults (data shown
in File S1, Table S1, S2).
The offspring generation was established by using only eggs laid
by 3-day-old females, i.e. - in the case of offspring derived from
treated parents - five days after the parental priming treatment in
the pupal stage. Thus, we could exclude that variation in offspring
immune responses were due to different time intervals between
parental treatment and egg deposition. Different time intervals
between these events were shown to affect offspring immunity
[22].
Offspring Culturing and Treatment
Eggs laid by different females originating from different
generations were taken to rear the offspring used for the
experiments. Freshly laid eggs of each parental group were taken
from the oviposition jar in a cage and placed on artificial diet (see
above) in small plastic cups (diameter 8 cm, height 6 cm, five eggs
per cup). Larvae were maintained in these cups with five larvae per
cup until the 4th instar, whereas 5th instar larvae were kept in
larger boxes with three larvae per box (1361766 cm) which were
cleaned and filled with fresh artificial diet every other day.
Keeping the larvae at these densities ensured avoidance of density-
dependent effects on immunity [56]. When larvae reached the
wandering stage, they were kept further on in the larger boxes, but
were no longer provided with diet; the boxes were only lined with
household paper. Pupae were separated by sexes, and always 10
pupae were kept in the larger boxes between two layers of
household paper. Adults eclosed in 50650650 cm cages and were
provided with 10% aqueous honey solution. None of the offspring
individuals used for immunity measurements was returned to the
experimental rearing.
In order to examine the impact of the parental priming
treatment on M. sexta offspring immunity, (i) immunity of different
unchallenged offspring life stages (2nd –5th instar larvae, wandering
larvae, pupae, and adults) (Fig. 1, Table 1, Table S3, S4 in File S1)
and (ii) immune responses of challenged 4th instar larvae and
pupae of naive, PBS- and PGN-treated parents were compared
(Fig. 2, Table 2, Table S5, S6 in File S1). Offspring larvae, pupae
and adults from each parental group were sampled at the first day
of each developmental stage in order to measure immune
parameters of unchallenged offspring. In addition, unchallenged
22-day-old offspring pupae of each parental treatment group were
sampled for immunity measurements of unchallenged offspring.
The offspring immune system was challenged by PGN injection.
For control, offspring larvae and pupae received a PBS injection or
were left untreated (naive). Larvae (4th instar) were treated at the
day of molting, and haemolymph was sampled one day later. Nine
offspring larvae were sampled at random from each parental
group and received a single injection of either 25 mL PGN solution
(2 mg PGN/mL PBS) or 25 mL PBS solution through the ‘horn’ on
the terminal abdominal segment. The PGN- and PBS-treatments
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of 21-day-old pupae were conducted in the same way as described
above for the parental generation.
In order to investigate the impact of the parental priming
treatment on the time for which a once enhanced immune activity
level persists after immune challenge in the offspring, haemolymph
was sampled three days (in 1-day-old adults), and five days (in 3-
day-old adults) after treatment of offspring pupae from each
parental group (Fig. 3, Table 3, Table S7, S8 in File S1). At each
time point nine offspring individuals were sampled at random for
each offspring immune treatment (naive, PBS, PGN; i.e. in total,
162 individuals were analysed; 3 immune treatments for offspring
pupae, 3 parental groups, 2 measurement time points, 9 offspring
adults per group: 3636269 = 162).
Sampling Haemolymph
All individuals were surface-sterilised with a 70% ethanol-
soaked paper towel prior to handling. We determined the immune
activity of haemolymph taken from chilled larvae, pupae and
adults. Larval haemolymph was removed from an incision made in
the ‘horn’ with scissors; wounding of other developmental stages
was conducted with a scalpel. Haemolymph of wandering larvae
was taken from a wound inflicted to the last proleg. Pupal
haemolymph was collected from a dorsal cut between thorax and
abdomen. Adult haemolymph was taken from a ventral cut
between the second and third thoracic segment of which hairs
were removed. In pupae, we first differentiated between male and
female haemolymph samples. Pilot experiments revealed that this
M. sexta stage which we challenged in the parental generation did
not show sexual dimorphism in immune responses (Table S2 in
File S1). Hence, we did not separate haemolymph samples of
pupae and adults according to sex in our further experiments since
our studies focussed on the impact of parental priming on the
different offspring developmental stages rather than on the
elucidation of sex-specific TGIP effects. Haemolymph that
emerged from the experimentally inflicted injuries of larvae
(different instars at the day of molting), wandering larvae (at the
day of aorta exposure), pupae (1- and 22-day-old) and adults (1-
and 3-day-old) was sucked with a 10 mL-pipet into pipet tips
(L2:1 mL, L3:2 mL, L4– adults: 6–12 mL per individual). We did
not collect haemolymph of L1 larvae since they are too small for
haemolymph sampling. Nine samples were collected for each
developmental stage and treatment. To obtain enough haemo-
lymph for the assays, one sample of L2 haemolymph consisted of
haemolymph that was pooled from six individuals, and one sample
of L3 haemolymph was pooled from three individuals, whereas
each sample of haemolymph of other stages was obtained from a
single individual. Haemolymph samples were immediately diluted
1:5 in anticoagulant buffer (4 mM NaCl, 40 mM KCl, 4 mM
EDTA, 4.8 mM citric acid, 13.6 mM sodium citrate, 5%
saccharose, 0.1% polyvinylpyrrolidone, 1.9 mM PIPES, pH 6.8),
frozen in liquid nitrogen, and stored at 280uC until used for
analysis.
Immune Parameters
As proxy for the activity of the immune status of parental and
offspring stages we measured phenoloxidase (PO) and antibacterial
activity of the haemolymph of juvenile and adult stages. Samples
for analyses of PO and antibacterial activity were kept frozen and
thawed on ice directly prior to analysis.
(a) Phenoloxidase (PO) activity. A haemolymph sample
(5 mL) was diluted 1:2 in Na2HPO4 and used for a dot blot
assay as described by [57], but modified as follows: instead of
10 mM Na2HPO4, we used a 1 mM concentration of this
buffer; a dilution series (200.0, 100.0, 50.0, 20.0, 10.0, 5.0,
2.5, 1.7, 1.25, 161023) of fountain pen ink (Pelikan 4001
brillant black, Hannover, Germany) was used to establish a
calibration curve (formular of calibration: value of measured
darkness = 12.7ln(ink dilution) –96.8 to compute the mela-
nisation index [ink dilution61023]); dry filterpapers were
scanned with AlphaImagerH (Alpha Innotech, Kasendorf,
Germany). A control of each sample on a filter paper pre-
soaked with 1 mM Na2HPO4 was used to measure the
darkness and the spontaneous PO activity of the samples.
The value of the control measurement without L-Dopa was
subtracted from the L-Dopa measurement to calculate the
value of measured darkness. Data are presented as
melanisation index per individual. Hence, measurements of
L2 haemolymph were always divided by 6, and those of L3
haemolymph were always divided by 3 (compare above,
haemolymph sampling).
(b) Antibacterial activity. A haemolymph sample (5 mL) was
diluted 1:4 in PBS before measurement. Test plates
(12612 cm) were prepared by adding 2.5 mL of PBS-
washed M. luteus (DSM 20030, DSMZ, Braunschweig,
Germany) bacteria suspension (OD620 = 0.6) to 25 mL
sterile medium (5 g yeast extract, 5 g pepton in 1 L distilled
water, pH 7.0, 1.5% agar). A cork borer was used to punch
25 wells in one agar plate. A volume of 20 mL of each sample
solution was added to each well. Plates were incubated for
24 h at 30uC. A dilution series of chicken lysozyme (Sigma;
500.0, 250.0, 125.0, 62.5, 31.3, and 15.6 mg mL21) was
applied to each plate to generate a calibration curve based
on these standards. Antibacterial activities were determined
as lysozyme equivalents calculated from the radius of the
clear zone around a sample well. Data are given in lysozyme
equivalents per individual; hence, data of L2 haemolymph
were always divided by 6, and data of L3 haemolymph were
always divided by 3 (compare above, haemolymph sam-
pling).
Increase of PO or antibacterial immune activity in the
challenged larval, pupal and adult offspring was analysed for each
parental group by comparing the activity elicited by PBS or PGN
treatment with the activity in the haemolymph of unchallenged
individuals (Fig. 2). We calculated for each developmental stage
studied:
Increase of immunity~
Activity after PGN treatment
Mean activity of unchallenged individuals
Data that were used to calculate the increase are shown in
Table S5 in File S1. Increase calculation allows a comparison
between the immune activities of the different immunochallenged
developmental stages.
Offspring Weight, Developmental Time and Fecundity
In order to elucidate benefits and costs of the parental priming
treatment in course of the development of the offspring generation,
we recorded the following parameters: weight of each stage from
2nd instar to adult, developmental time of each life stage from egg
to adult (Fig. 4, Table 4, Table S9, S10, S11 in File S1), and the
number of eggs that were laid per female in the parental and the
offspring generation (Fig. 5, Table 5).
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Eighteen eggs of each parental group were taken from the
oviposition jars in the cages with the respective parents. Each egg
was placed individually in a small cup (diameter 8 cm, height 6 cm)
on artificial diet (see above) under the abiotic conditions used for M.
sexta rearing. Larvae were fed ad libitum on artificial diet. The 5th
instar larvae and wandering larvae were kept in larger boxes
(1361766 cm). Larval weight was recorded at the last day of each
instar. Pupae and adults were weighed at the first day of the
respective life stage. To record fecundity, offspring females were kept
individually with one male derived from the same parental
treatment at the conditions as described above for the M. sexta
rearing.
To compare weight and developmental time of offspring
derived from naive parents with offspring from parents that
received a priming treatment we calculated the ratios of weight or
developmental time between offspring from naive parents and
PBS- or PGN-treated parents:
Ratio ~
Individual weight or developmental time
Mean weight or developmental time of offspring from naive parents
Data that were used to calculate these ratios are shown in Table
S9 in File S1. Ratio calculation allows a comparison between the
performance parameter of the different developmental stages.
Statistics
All statistical analyses were conducted with R 2.12.0 (R
Developmental Core Team, 2010). Data were analysed using
descriptive statistics and were tested for normality by Shapiro-Wilk
test and for variance homogeneity by Levene test. The data were
Box-Cox transformed to reach normal distribution if necessary.
To determine whether a parental immune challenge affected
the immunity of unchallenged offspring individuals differently in
the different offspring developmental stages, PO and antibacterial
activities of the offspring were analysed by a two-way-ANOVA
(factors: (i) parental treatments: naive, PBS, PGN and (ii) offspring
stage: 2nd, 3rd, 4th, 5th larval instar, wandering larvae, 1-day- and
22-day-old pupae, 1-day-old adults (Table 1 for ANOVA, Fig. 1)).
Finally, a post-hoc Tukey test was performed to compare the
different developmental stages of the three parental treatment
groups stage by stage (Table S3 for PO activity in File S1) or to
compare the different developmental stages (Table S4 for
antibacterial activity in File S1).
The effects of an immune challenge of offspring individuals on
immune activities were expressed as increase of immunity in
immunochallenged offspring individuals when compared to
untreated ones (see more detailed explanation above). In order
to determine whether the different parental treatments affected
the immunity of PGN-immunochallenged offspring individuals
differently with respect to the offspring developmental stage that
was challenged, data were analysed by using a two-way-ANOVA
(factor: (i) parental treatments: naive, PBS, PGN and (ii) offspring
stage: 4th larval instar, 22-day-old pupae). Fig. 2 and Table 2
(ANOVA) show the results obtained from the comparison of
PGN-challenged offspring of the three parental treatment groups.
Table S5 in File S1 presents the absolute data (no increase data).
For control, Table S6 (ANOVA) in File S1 shows the results
obtained from the comparison of PBS-treated offspring of the
three parental treatment groups with respect to the question
whether the different parental treatments affected the immunity
of PBS-treated offspring individuals differently.
In order to elucidate whether the parental treatment affects the
persistence of immune activity of the PGN-treated offspring, data
were analysed by using a two-way-ANOVA (factor: (i) parental
treatments: naive, PBS, PGN and (ii) time after immune offspring
immune challenge: 3 days (1-day-old adults), 5 days (3-day-old
adults)). Fig. 3 and Table 3 (ANOVA) show the results obtained
from the comparison of PGN-challenged offspring of the three
parental treatment groups. Table S5 in File S1 presents the
absolute data (no increase data). The antibacterial activities of
challenged offspring adults of the different parental treatment
groups were compared by a post-hoc Tukey test (Table S7 in File
S1). For control, Table S8 in File S1 shows the results obtained
from the comparison of PBS-treated offspring of the three parental
treatment groups with respect to question for how long the
parental treatment effects on the immunity of pupae persist after
pupal PBS treatment.
The effects of the parental immune treatment on offspring weight
and development time were expressed as ratio of the performance
parameter of offspring from PGN (PBS)-challenged parents and
untreated parents (see more detailed explanation above). The ratio
expresses the increase or decrease in performance in dependence of
the parental treatment. In order to determine whether the different
parental treatments affected the weight or developmental time of the
offspring individuals differently with respect to the offspring
developmental stage, data were analysed by using a generalized
linear model (GLM) since the data did not show homogeneity of
variance nor normal distribution (factor: (i) parental treatments:
naive, PBS, PGN and (ii) offspring stage: 2nd, 3rd, 4th, 5th larval instar,
1-day-old pupae, 1-day-old adults). Fig. 4A, B and Table 4 (GLM)
show the results obtained from the comparison of the offspring of the
three parental treatment groups. Table S9 in File S1 presents the
absolute data (no ratios). The weights of the different offspring stages
were compared by post-hoc U tests with Benjamini-Hochberg
correction (Table S10 in File S1). The ratios of developmental time
of the different developmental stages of the three parental treatment
groups were compared stage by stage by a post- hoc U-test with
Benjamini-Hochberg correction (Table S11 in File S1).
In order to determine whether fecundity in the parental and the
offspring generation changed due to the parental priming
treatment, data were analysed using a two-way-ANOVA with
parental treatments (naive, PBS, PGN) and generation (parental
generation and offspring generation) as factors (Table 5, Fig. 5).
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